Eiger BioPharmaceuticals
company
Funding Rounds
Number of Funding Rounds
Total Funding Amount
11
$156.26M 0
Eiger BioPharmaceuticals has raised a total of
$156.26M 0 in funding over 2 rounds. Their latest funding was raised on
Jun 7, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 7, 2022 | Post-IPO Debt | $75M | 1 | Innovatus Capital Partners | — | Detail |
| Jun 7, 2022 | Post-IPO Equity | $5M | 1 | Innovatus Capital Partners | — | Detail |
| Oct 26, 2017 | Post-IPO Equity | $19.50M | — | — | — | Detail |
| Jan 4, 2017 | Post-IPO Debt | $25M | 1 | Oxford Finance LLC | — | Detail |
| Apr 29, 2016 | Post-IPO Equity | $2.99M | — | — | — | Detail |
| Mar 23, 2016 | IPO | — | — | — | — | Detail |
| Mar 21, 2016 | Debt Financing | — | 1 | — | — | Detail |
| Nov 23, 2015 | Debt Financing | $6M | — | — | — | Detail |
| Apr 15, 2011 | Series A | $14.46M | 2 | — | — | Detail |
| Feb 25, 2009 | Series A | $8.30M | 2 | InterWest Partners , Vivo Capital | — | Detail |
| Jan 1, 2007 | Seed | — | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
